SLC1A2 and amyotrophic lateral sclerosis: Just recently, a prominent reduction in EAAT2 immunoreactivity was reported in an independent rodent model for ALS, rats expressing ALS-inducing mutant TAR DNA binding protein 43 in astrocytes only (Tong et al., 2013).